Cronos Group Inc.
Cronos Group Inc. (CRON.TO) Financial Performance & Income Statement Overview
Review Cronos Group Inc. (CRON.TO) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Cronos Group Inc. (CRON.TO) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Cronos Group Inc. CRON.TO financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $32.26M | $30.30M | $34.26M | $27.76M |
| Cost of Revenue | $18.53M | $19.49M | $30.65M | $21.46M |
| Gross Profit | $13.73M | $10.81M | $3.61M | $6.30M |
| Gross Profit Ratio | $0.43 | $0.36 | $0.11 | $0.23 |
| R&D Expenses | $793000.00 | $1.03M | $1.24M | $962000.00 |
| SG&A Expenses | $15.96M | $20.68M | $20.55M | $19.33M |
| Operating Expenses | $17.81M | $22.17M | $37.27M | $21.86M |
| Total Costs & Expenses | $36.33M | $41.67M | $67.92M | $43.32M |
| Interest Income | $9.66M | $11.86M | $12.46M | $13.45M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $2.84M | $2.52M | $3.57M | $1.51M |
| EBITDA | -$677000.00 | -$8.84M | -$15.71M | -$13.50M |
| EBITDA Ratio | -$0.02 | -$0.29 | -$0.46 | -$0.49 |
| Operating Income | -$4.07M | -$11.37M | -$33.66M | -$15.56M |
| Operating Income Ratio | -$0.13 | -$0.38 | -$0.98 | -$0.56 |
| Other Income/Expenses (Net) | $11.34M | $57.31M | $38.27M | $4.63M |
| Income Before Tax | $7.27M | $45.95M | $4.62M | -$10.93M |
| Income Before Tax Ratio | $0.23 | $1.52 | $0.13 | -$0.39 |
| Income Tax Expense | -$455000.00 | $2.004M | -$2.71M | -$2.17M |
| Net Income | $6.12M | $43.73M | $8.35M | -$8.76M |
| Net Income Ratio | $0.19 | $1.44 | $0.24 | -$0.32 |
| EPS | $0.01 | $0.11 | $0.02 | -$0.02 |
| Diluted EPS | $0.01 | $0.11 | $0.02 | -$0.02 |
| Weighted Avg Shares Outstanding | $306.10M | $382.16M | $382.16M | $382.16M |
| Weighted Avg Shares Outstanding (Diluted) | $306.10M | $382.16M | $382.16M | $382.16M |
Over the past four quarters, Cronos Group Inc. demonstrated steady revenue growth, increasing from $27.76M in Q2 2024 to $32.26M in Q1 2025. Operating income reached -$4.07M in Q1 2025, maintaining a consistent -13% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$677000.00, reflecting operational efficiency. Net income dropped to $6.12M, with EPS at $0.01. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan